PNOS 2025

Pediatric Oncology Is the Nimotuzumab-Vinorelbine Combination Worth the Cost in Pediatric Diffuse Midline Gliomas?
Selma Çakmakcı • Arzu Yazal Erdem • Harun Demirci • Servet Güreşçi • Süheyla Aytaç Arslan • Derya Özyörük • Neriman Sarı
doi.org/10.69690/ODMJ-018-0915-5355
Pediatric Oncology Posterior Fossa Ependymoma in a Child with Neurofibromatosis Type 1: A Rare Association
Muhammad Kashan • Sundus Hashmani • Ahila Ali • Musfira Ayaz
doi.org/10.69690/ODMJ-018-0915-5315
Pediatric Oncology Myxoid Glioneuronal Tumor – Systematic Review of Clinico-Radiological Manifestations and Multimodal Management
Haseeb Mehmood Qadri • Nasruddin Ansari • Asif Bashir
doi.org/10.69690/ODMJ-018-0915-5281
Pediatric Oncology Treatment outcomes of pineal region lesions: 23-year experience from a tertiary care center
Komal Naeem • Zunaira Saeed • Syed Murtaza Nawab • Afia Salman • Malaika Siddiqui • Shilpa Golani • Haseeb Qadri • Hamza Khan • Syed Ather Enam
doi.org/10.69690/ODMJ-018-0915-5252
Pediatric Oncology Barriers in Treating Pediatric Brain Tumors in Low-Middle-Income Countries: An insight from Pakistan
Alia Ahmad • Laeeq Ur Rehman • Stephen Francis • Roberta McKean-Cowdin • Joseph Leo Wiemels
doi.org/10.69690/ODMJ-018-0915-5272